Cellular Oxidative and Mitochondrial Stress Protection Compositions
Summary
NUCHIDO LIMITED filed USPTO Patent Application US20260090969A1 for compositions protecting cells from oxidative and mitochondrial stress. The application discloses a combination of bioactive compounds including NMN, NR, resveratrol, curcumin, and other cellular stress protectors for pharmaceutical and cosmetic applications. Published April 2, 2026.
What changed
NUCHIDO LIMITED, through inventors Nichola Jane Conlon and Malcolm Philip Young, filed a patent application covering compositions comprising combinations of cellular stress-protecting compounds. The disclosed compounds include over 60 different bioactive agents such as nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), resveratrol, curcumin, quercetin, fisetin, berberine, and various botanical extracts. The application is classified under A61K (preparations for medical, dental, or toilet purposes) with specific focus on A61K 8/675, A61Q 19/08 (anti-aging cosmetics).
This patent application does not impose any compliance requirements or deadlines on third parties. Companies developing supplements, cosmetics, or pharmaceuticals targeting cellular health, anti-aging, or mitochondrial function should monitor the prosecution of this application to assess potential freedom-to-operate implications. The application has no stated comment period or compliance deadline as it is a published patent application rather than a regulatory rulemaking.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS
Application US20260090969A1 Kind: A1 Apr 02, 2026
Assignee
NUCHIDO LIMITED
Inventors
Nichola Jane Conlon, Malcolm Philip Young
Abstract
There are described compositions comprising an effective amount of a combination of two or more components, said components selected from acacetin, ACTI peptide, alpha-lipolic acid, alprostadil, anisomycin, apigenin, ascorbic acid, astragalus, berberine, β-lapachone, β-hydroxy-beta-methyl-butyrate, Bacopa monnieri, catechin, catechol, chamomile, chrysin, coumestrol, curcumin, dinitrophenol, dinoprost, ellagic acid, (−)-epigallocatechin gallate, green tea extract, fisetin, genistein, ginsenoside RE, glabridin, 18-α-glycyrrhetinic acid, 18-β-glycyrrhetinic acid, glycyrrhizin, hydroquinone, isoquercitrin (EMIQ), kaempferol, kuromanin, leucine, lithium, luteolin, luteolin, luteolinidin, melatonin, menadione, 1-methylnicotinamide (MNA), methyl salicylate, myricetin, nadide, niacin (vitamin B3), nicotinamide (NAM), nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), nicotinic acid adenine dinucleotide (NaAD), nicotinic acid mononucleotide (NaMN), parsley (Petroselinium crispum), phenylephrine, pokeweed mitogen, 15-Δ prostaglandin J2, puromycin, quercetin, quinolinic acid, retinoic acid, trichostatin A, troxrutin, rutin, tryptophan, vitamin D3, withaferin A, wortmannin and zinc (including salts thereof).
CPC Classifications
A61K 8/675 A61K 8/27 A61K 8/498 A61K 8/676 A61K 31/352 A61K 31/375 A61K 31/455 A61K 33/30 A61Q 19/08 A61K 2800/92
Filing Date
2025-06-30
Application No.
19255485
Named provisions
Related changes
Get daily alerts for ChangeBridge: Patent Apps - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Pharma (A61K) publishes new changes.